Added to YB: 2025-08-19
Pitch date: 2025-08-16
RCEL [neutral]
AVITA Medical, Inc.
-37.32%
current return
Author Info
Steve Wagner provides in-depth analysis of my favorite individual companies. Sign up for the newsletter.
Company Info
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
Market Cap
$149.6M
Pitch Price
$5.52
Price Target
N/A
Dividend
N/A
EV/EBITDA
-4.05
P/E
-2.86
EV/Sales
2.38
Sector
Biotechnology
Category
turnaround
From Rockets to Runways to Payment Rails — 7 Q2 Earnings in Focus - AVITA Medical, Inc.
RCEL (earnings update): Now in 'survival mode' with slower revenue ramp, delayed breakeven & dilution risk. Revised investment case reflects lower near-term growth, higher share count, but platform remains valuable if execution stabilizes post-2026.
Read full article (1 min)